Market Cap 36.48M
Revenue (ttm) 0.00
Net Income (ttm) -29.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 76.44
Volume 85,301
Avg Vol 577,728
Day's Range N/A - N/A
Shares Out 10.19M
Stochastic %K 99%
Beta 1.25
Analysts Strong Sell
Price Target $11.20

Company Profile

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, which is in...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 7 4719 5700
Address:
18 Hasivim Street, Petah Tikva, Israel
Kevin73ca
Kevin73ca Jun. 26 at 7:06 PM
$PRFX Israel based Lots of pharma companies I noticed $PYPD
0 · Reply
TheMFBearKillla
TheMFBearKillla Jun. 26 at 7:33 AM
$PYPD TheMFBK
0 · Reply
Project_Profit
Project_Profit Jun. 25 at 10:35 PM
$PYPD has approximately 17,817,418 shares outstanding.
1 · Reply
huskyd97
huskyd97 Jun. 25 at 9:19 PM
$PYPD market cap ridiculously low, 4 million float too? Im in this could rocket at any moment.
1 · Reply
Project_Profit
Project_Profit Jun. 25 at 8:01 PM
$PYPD great strong close! Something is brewing!!!
1 · Reply
Fredzel
Fredzel Jun. 24 at 1:31 PM
$PYPD https://www.msn.com/en-us/money/markets/polypid-price-target-raised-to-13-from-11-at-h-c-wainwright/ar-AA1GnJXr
0 · Reply
Lalalilala
Lalalilala Jun. 24 at 10:43 AM
$PYPD Good !
0 · Reply
Fredzel
Fredzel Jun. 23 at 8:17 PM
$PYPD 7.40 🫡🇮🇱
0 · Reply
Project_Profit
Project_Profit Jun. 23 at 8:05 PM
$PYPD nice day! Leg up tomorrow?
0 · Reply
liquidtrading91
liquidtrading91 Jun. 23 at 7:29 PM
$PYPD Just added 4000 shares
0 · Reply
Latest News on PYPD
PolyPid Ltd. (PYPD) Q1 2025 Earnings Call Transcript

May 14, 2025, 1:24 PM EDT - 6 weeks ago

PolyPid Ltd. (PYPD) Q1 2025 Earnings Call Transcript


PolyPid to Participate in The Citizens Life Sciences Conference

Apr 22, 2025, 7:00 AM EDT - 2 months ago

PolyPid to Participate in The Citizens Life Sciences Conference


PolyPid to Participate in the 37th Annual ROTH Conference

Mar 3, 2025, 7:00 AM EST - 4 months ago

PolyPid to Participate in the 37th Annual ROTH Conference


PolyPid Ltd. (PYPD) Q4 2024 Earnings Call Transcript

Feb 12, 2025, 10:44 AM EST - 4 months ago

PolyPid Ltd. (PYPD) Q4 2024 Earnings Call Transcript


PolyPid Ltd. (PYPD) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 2:06 PM EST - 8 months ago

PolyPid Ltd. (PYPD) Q3 2024 Earnings Call Transcript


PolyPid Ltd (PYPD) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 1:25 PM EDT - 11 months ago

PolyPid Ltd (PYPD) Q2 2024 Earnings Call Transcript


PolyPid Ltd (PYPD) Q1 2024 Earnings Call Transcript

May 9, 2024, 10:38 PM EDT - 1 year ago

PolyPid Ltd (PYPD) Q1 2024 Earnings Call Transcript


PolyPid Ltd (PYPD) Q4 2023 Earnings Call Transcript

Feb 14, 2024, 11:13 AM EST - 1 year ago

PolyPid Ltd (PYPD) Q4 2023 Earnings Call Transcript


PolyPid Ltd. (PYPD) Q3 2023 Earnings Call Transcript

Nov 12, 2023, 1:08 AM EST - 1 year ago

PolyPid Ltd. (PYPD) Q3 2023 Earnings Call Transcript


Kevin73ca
Kevin73ca Jun. 26 at 7:06 PM
$PRFX Israel based Lots of pharma companies I noticed $PYPD
0 · Reply
TheMFBearKillla
TheMFBearKillla Jun. 26 at 7:33 AM
$PYPD TheMFBK
0 · Reply
Project_Profit
Project_Profit Jun. 25 at 10:35 PM
$PYPD has approximately 17,817,418 shares outstanding.
1 · Reply
huskyd97
huskyd97 Jun. 25 at 9:19 PM
$PYPD market cap ridiculously low, 4 million float too? Im in this could rocket at any moment.
1 · Reply
Project_Profit
Project_Profit Jun. 25 at 8:01 PM
$PYPD great strong close! Something is brewing!!!
1 · Reply
Fredzel
Fredzel Jun. 24 at 1:31 PM
$PYPD https://www.msn.com/en-us/money/markets/polypid-price-target-raised-to-13-from-11-at-h-c-wainwright/ar-AA1GnJXr
0 · Reply
Lalalilala
Lalalilala Jun. 24 at 10:43 AM
$PYPD Good !
0 · Reply
Fredzel
Fredzel Jun. 23 at 8:17 PM
$PYPD 7.40 🫡🇮🇱
0 · Reply
Project_Profit
Project_Profit Jun. 23 at 8:05 PM
$PYPD nice day! Leg up tomorrow?
0 · Reply
liquidtrading91
liquidtrading91 Jun. 23 at 7:29 PM
$PYPD Just added 4000 shares
0 · Reply
pandodark
pandodark Jun. 23 at 3:46 PM
$PYPD Massive upside potential.
0 · Reply
huskyd97
huskyd97 Jun. 23 at 3:43 PM
$PYPD lets get it. My sleeper!
0 · Reply
sxpl
sxpl Jun. 23 at 3:37 PM
$PYPD 💪🏼🚀
0 · Reply
WallStWireAds
WallStWireAds Jun. 23 at 11:25 AM
$PYPD https://thefinanceherald.com/with-fresh-funding-and-strong-phase-3-data-polypid-advances-towards-fda-approval/
0 · Reply
Lalalilala
Lalalilala Jun. 20 at 6:14 AM
$PYPD PolyPid was present at BIO2025, but only for private meetings (1-on-1 via BIO partnering app) and not for a public presentation or formal session. There are no reports of their participation (no replay, no summary, nothing released in the press or on their IR site).
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Jun. 19 at 10:56 PM
$SLS $ANRO $PYPD $CING $ATHE Gps will Set Records for Patient Uptake rates, with 3x 4x OS Advantages, NO Serious Side Effects, Easy Administration, ease of and low cost of Manufacture, High Margin, Fast Track, Orphan Designation, IP rights to 2035 --- CCO Est at $260K Per Patient Per Year, 25,000 AML patients /y + 75K Now in Remission who'll immediately benefit out of the Gate - BLA in H2 2025. @FireFoxF10 -- the calculations continue to increase. Just in the Last Month, we See 009 Will be efficacious for 12,000 MSI-H CRC patients each year - what do you think that is worth? and also, GPs Immunotherapy Regime has been Extended - beyond 12 months at Clinicians Requests, - more than 75% 80% of Patients will continue on Treatment - we know from the Statistically Significant P2 about half will live at least 2 years, and the CEO just disclosed at the ASM, GPs Patients surviving beyond 3 years --- the $6B GPS TAM --- now looks to be Closer to $10B Just for AML Remission. You Tell Me.
1 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Jun. 19 at 9:38 PM
$SLS Phase 3, FDA Registrational Results - Worth Literally $10B + to Big Pharma Will BE Announced - ANY DAY NOW. GPs, an Immunotherapy for AML Remission Maintenance - 5 years in the Making and Imminent. - CEO Disclosed patients on GPs are Living 3+ Years - vs Dr's who Treat Actual P3 Control Patients Stating OS is Only 6-8 months with Best Available Treatments. Cash Runway into Q3, 2026 and More Cash Coming. This Short Manipulated equity offers the Investment Opportunity of a Lifetime. Institutional Investment up to 59 funds, 34% vs 38 funds 8% in Q3 2024 - INSIDERS PURCHASING on the Open Market - 99.9 to .01 CALL to Put Ratio. $ANRO $PYPD $CING $ATHE
0 · Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX Jun. 19 at 9:16 PM
$SLS Over the next few months, I'm expecting some solid moves: Riley (90% conviction for 100% gain) should pop by mid-August, $ANRO (80% conviction for 140% gain) in the next couple weeks, $ATHE (75% for 50% gain) sometime in two months, $CING (70% for 200% gain) in three, and $SLS (90% for 600% gain) in four, $PYPD (95% for 100% gain) eoy. When each one jumps, I'll cash out some profits-keeping 20% to stash in my long-term port. The rest of the gains get split between whatever plays are still active.... ignoring my 5% rule, as I'm considering this as one play. As each stock hits, the leftover money keeps cycling forward, giving me more firepower for the next move... I think each move, will be enough of a move, I only need to be right on a few of these. 50:50 shares/call splits on ANRO and SLS RILY 30/70 shares/calls. Everything else is shares only. GLTAL... eh... actually... good luck to most of you... a couple of you really suck. Bullish
4 · Reply
Lalalilala
Lalalilala Jun. 18 at 5:31 PM
$PYPD Damn, I didn't pick the best time to get in! This drop to $3.30 is just annoying before Thursday when the market is closed.....We'll see next Monday what their presentation was like. Target $7 for me.
0 · Reply
JarvisFlow
JarvisFlow Jun. 18 at 4:33 PM
Roth Capital has adjusted their stance on PolyPid ( $PYPD ), setting the rating to Buy with a target price of 12 → 9.
0 · Reply
WallStWireAds
WallStWireAds Jun. 18 at 4:01 PM
$PYPD https://www.benzinga.com/content/45999748/with-fresh-funding-and-strong-phase-3-data-polypid-advances-towards-fda-approval
0 · Reply
WallStWireAds
WallStWireAds Jun. 17 at 9:28 PM
$PYPD https://thefinanceherald.com/with-fresh-funding-and-strong-phase-3-data-polypid-advances-towards-fda-approval/
0 · Reply